Breast cancer and antidepressant use.
Department of Psychopharmacology, National Institute of Mental Health and Neurosciences, Bangalore, India. candrade@psychiatrist.com
Chittaranjan
C
Andrade
D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000009:adverse effects* / Q000494:pharmacology; D001007:Anxiety / Q000188:drug therapy; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000523:psychology; D000075202:Contraindications; D065690:Cytochrome P-450 CYP2D6 Inhibitors; D003863:Depression / Q000188:drug therapy; D004347:Drug Interactions; D005260:Female; D019584:Hot Flashes / Q000188:drug therapy; D006801:Humans; D017374:Paroxetine / Q000009:adverse effects* / Q000494:pharmacology; D011355:Prodrugs; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology*; D016019:Survival Analysis; D013629:Tamoxifen / Q000494:pharmacology*
D000928:Antidepressive Agents; D065690:Cytochrome P-450 CYP2D6 Inhibitors; D011355:Prodrugs; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D017374:Paroxetine